OraSure Technologies, Inc. (NASDAQ:OSUR)
CAPS Rating:
The Company develops, manufactures and markets oral specimen collection devices using its proprietary oral fluid technologies, diagnostic products including in vitro diagnostic tests, and other medical devices.
RSS Headlines
Fool UK
Recs
Quick test result product for Hep. C due in 2011. Testing is where it is at for the future.